
Loading, please wait...

Loading, please wait...

Recently, Chennai witnessed the launch of iLive Connect, a doctor-led ecosystem focused on AI healthcare monitoring. This innovative platform uses a wireless biosensor patch and a wearable wristband to track vital parameters in real-time. Consequently, clinicians can supervise patients outside traditional hospital settings. Since India faces a high cardiovascular burden, this technology aims to reduce sudden cardiac deaths effectively. Moreover, the system facilitates early identification of potential risks before they escalate into serious illnesses.
Experienced doctors at a remote command center track physiological data 24/7. They alert families immediately if they detect any clinical abnormalities in the patient. Dr. Rahul Chandola emphasized that traditional symptom-driven care often proves inadequate for asymptomatic individuals. Therefore, continuous monitoring helps identify subclinical issues that episodic evaluations might miss. Furthermore, the platform allows for multi-day screenings to capture data under real-world conditions, providing a comprehensive profile for early risk stratification.
The technology specifically addresses the vulnerable post-discharge phase for surgical patients. Patients often face high risks during the first month after leaving the hospital. Additionally, this platform manages chronic conditions like diabetes, hypertension, and asthma. Elderly patients living independently also benefit from this constant medical support and access to doctors. Ultimately, these systems ensure continuity of care and minimize unrecognized complications during the recovery process. This approach significantly reduces the likelihood of emergency readmissions.
Q1: What specific parameters does the iLive Connect patch monitor?
The wireless biosensor patch and wristband monitor critical vital parameters including heart activity and blood pressure in real-time.
Q2: How does the system help patients with chronic conditions like diabetes?
The platform provides ongoing physiological monitoring and data-driven alerts, helping clinicians manage conditions like diabetes, hypertension, and COPD remotely.
Q3: Why is continuous monitoring better than traditional check-ups?
Continuous monitoring identifies transient or subclinical abnormalities that doctors might miss during standard, single-point diagnostic tests or episodic hospital visits.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Chennai introduces iLive Connect, a doctor-led AI platform for 24/7 remote monitoring of cardiac and chronic conditions to improve patient outcomes....
6 months ago

A breakthrough study evaluated H5N1 transmission efficiency across mammalian isolates. Researchers discovered that human-derived D1.1 harboring the PB2 D701N mutation spread efficiently in ferrets, unlike strains carrying PB2 E627K. This finding highlights critical genetic markers for zoonotic surveillance.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today